Merck Sets Aside $950M For Federal Vioxx Settlement
Merck said the settlement reserve was established in connection with “an anticipated resolution” of a previously disclosed investigation by the U.S. Attorney's Office for the District of Massachusetts, according to its third-quarter earnings statement. The office's health fraud task force is leading the investigation.
Whitehouse Station, N.J.-based Merck disclosed in...
To view the full article, register now.